PTIXW icon

Protagenic Therapeutics Warrant
PTIXW

6 hedge funds and large institutions have $2.63K invested in Protagenic Therapeutics Warrant in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$750
2
+$18

Top Sellers

1
-$127
2
-$61
3
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Warberg Asset Management
Illinois
$1.28K
CS
2
Clear Street
New York
$750
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$376
GS
4
GTS Securities
New York
$202
UBS Group
5
UBS Group
Switzerland
$21
TSS
6
Two Sigma Securities
New York
–